PEH's Portfolio Company Enanta announces U.S. FDA Approval for AbbVie's VIEKIRA PAK(TM)
Private Equity Holding AG /PEH's Portfolio Company Enanta announces U.S. FDA Approval for AbbVie's VIEKIRA PAK(TM) . Verarbeitet und übermittelt durch NASDAQ OMX Corporate Solutions.Für den Inhalt der Mitteilung ist der Emittent verantwortlich.Source: Globenewswire
Zug, December 22, 2014Enanta Pharmaceutical Inc., (NASDAQ: ENTA) a research and development-focusedbiotechnology company dedicated to creating small molecule drugs primarily inthe infectious disease field is Private Equity Holding AG's largest directinvestment. Enanta has announced that the U.S. Food and Drug Administration hasapproved AbbVie's VIEKIRA PAK(TM) for the Treatment of Chronic Genotype 1Hepatitis C Virus.The VIEKIRA PAK regimen contains Enanta's lead protease inhibitor paritaprevir(formerly ABT-450) and cured 95-100 percent of Hepatitis C patients, with lessthan two percent of patients experiencing virological failure in Phase 3clinical trials. For more information, please refer tohttp://ir.enanta.com/phoenix.zhtml?c=147990&p=irol-newsArticle&ID=2001257.PEH had invested in Enanta in 1999 as part of the original shareholder syndicateand backed the current management team through a strategic reorientation of thebusiness in 2002. PEH participated in several financing rounds thereafter andthe initial public offering in 2013 - all of which has created very significantvalue for PEH's shareholders to date.
***
Private Equity Holding AG (SIX: PEHN) offers investors the opportunity toinvest, within a simple legal and tax optimized structure, in a broadlydiversified and professionally managed private equity portfolio.For further information, please contact:Emanuel Eftimiu, Investor Relations, emanuel.eftimiu@peh.ch, phone+41 41 726 79 80, http://www.peh.ch
PEH_PR_141222: http://hugin.info/130308/R/1882491/664144.pdf
This announcement is distributed by GlobeNewswire on behalf of GlobeNewswire clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Private Equity Holding AG via GlobeNewswire[HUG#1882491]
http://www.peh.